biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > must read article

<< Previous

Bullboard Posts

Next >>

Comment by chrispion Jan 21, 2021 11:05am

166 Views

Post# 32344751

RE:RE:must read article

Hi Hemipizza,
you can read more in the Corporate Presentation on the Bioasis website or the 2 analyst reports (Zachs, and Edison Research) go into a lot more detail about the science that has already been demonstrated.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale